Lincoln National Corp Aspira Women'S Health Inc. Transaction History

Lincoln National Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$0.88 - $1.81 $22,000 - $45,250	-25,000 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$1.63 - $3.43 $94,006 - $197,818	-57,673 Reduced 69.76%	25,000 $44,000
Q1 2021 May 10, 2021	SELL	$5.9 - $9.13 $426,233 - $659,578	-72,243 Reduced 46.63%	82,673 $558,000
Q3 2020 Nov 09, 2020	BUY	$2.54 - $4.56 $25,400 - $45,599	10,000 Added 6.9%	154,916 $478,000
Q2 2020 Jul 31, 2020	BUY	$0.78 - $5.25 $113,034 - $760,809	144,916 New	144,916 $556,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.